- Peter Carmeliet
Peter Carmeliet is a Belgian MD and professor at the
Katholieke Universiteit Leuven (Leuven ,Belgium ). He is also Adjunct Director of the "VIB Department of Transgene Technology and Gene Therapy,K.U.Leuven ". One of his research interests arevasculogenesis ,angiogenesis andVascular endothelial growth factor (VEGF) [Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A, Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele, Nature 380, 435-439, 1996] [Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O’Shea KS, Powell-Braxton L, J. Hillan K, W. Moore M, Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene, Nature 380, 439-442, 1996] [Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De Mol M, Autiero M, Wyns S, Plaisance S, Moons G, Van Rooijen N, Giacca M, Stassen J, Dewerchin M, Collen D, Carmeliet P, Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels, Cell 131, 463-75, 2007] .Awards
*
2002 :Francqui Prize on Biological and Medical Sciences.
*2005 :Interbrew-Baillet Latour Health Prize , together withDésiré Collen [Bloom S., Belgian scientists awarded top honors, J Clin Invest. 2005 May;115(5):1106-7] .References
External links
* [http://www.kuleuven.be/cv/u0021003e.htm Peter Carmeliet, K.U.Leuven]
* [http://www.vib.be/Research/EN/Research+Departments/Department+of+Transgene+Technology+and+Gene+Therapy/Peter+Carmeliet/ Peter Carmeliet, VIB]
Wikimedia Foundation. 2010.
